WIN-Partners Co., Ltd. (TYO:3183)

Japan · Delayed Price · Currency is JPY

1,260.00

-24.00 (-1.87%)

Aug 5, 2026, 3:30 PM JST

-4.83% (1Y)

Market Cap	34.65B -5.4%
Revenue (ttm)	92.28B +11.0%
Net Income	2.04B +4.9%
EPS	73.71 +7.8%
Shares Out	27.50M
PE Ratio	17.09
Forward PE	n/a
Dividend	55.00 (4.28%)
Ex-Dividend Date	Mar 30, 2026

Volume	19,500
Open	1,270.00
Previous Close	1,284.00
Day's Range	1,258.00 - 1,281.00
52-Week Range	1,175.00 - 1,527.00
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents,... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1983

Employees 653

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 3183

Full Company Profile

Financial Performance

In fiscal year 2026, WIN-Partners's revenue was 90.39 billion, an increase of 11.03% compared to the previous year's 81.41 billion. Earnings were 2.12 billion, an increase of 4.90%.

Financial Statements